26 Jan 2015
A somatic mutation in the ATP-dependent helicase (ATRX) gene recently demonstrating potential as a molecular marker for aggressive brain tumours could also serve as a biomarker for rare neuroendocrine tumours, according to research published in Nature Communications. Healio
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024